Casdin Capital, LLC
Source: SEC Form 13F · as of Mar 2026Casdin Capital, LLC holds 23 biotech & pharma companies tracked by BioSniper, totaling $553.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$553.8M
| Company | Shares | Value |
|---|---|---|
| RVMDREVOLUTION MEDICINES, INC. | 2,577,333 | $250.6M |
| GPCRStructure Therapeutics Inc. | 1,175,000 | $56.6M |
| DNLIDenali Therapeutics Inc. | 1,840,000 | $35.3M |
| BEAMBeam Therapeutics Inc. | 1,350,000 | $32.2M |
| GHGuardant Health Inc. | 315,000 | $29.1M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 75,000 | $24.8M |
| MAZEMaze Therapeutics, Inc. | 758,857 | $22.7M |
| SRRKScholar Rock Holding Corp | 350,000 | $17.2M |
| TSHATaysha Gene Therapies, Inc. | 3,250,000 | $14.5M |
| QGENQIAGEN N.V. | 360,000 | $14.4M |
| SEPNSepterna, Inc. | 553,268 | $13.3M |
| DGXQuest Diagnostics Incorporated | 50,000 | $9.8M |
| MLTXMoonLake Immunotherapeutics | 450,000 | $8.4M |
| NTLAIntellia Therapeutics, Inc. | 355,000 | $4.6M |
| IRONDisc Medicine, Inc. | 65,000 | $4.2M |
| MRNAModerna, Inc. | 75,000 | $3.8M |
| GLUEMonte Rosa Therapeutics, Inc. | 186,014 | $3.1M |
| ABSIAbsci Corporation | 973,260 | $2.9M |
| IPSCCentury Therapeutics, Inc. | 1,228,190 | $2.8M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 282,312 | $2.5M |
| RXRXRECURSION PHARMACEUTICALS, INC. | 165,323 | $508K |
| TNYATenaya Therapeutics, Inc. | 361,969 | $251K |
| DNAGinkgo Bioworks Holdings Inc. | 36,493 | $224K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.